Repositori Obert UdL
Publicación
Artículo científico (JournalArticle)
Trioxidized cysteine and aging: a molecular binomial that extends far beyond classical proteinopathic paradigms
Increased oxidative stress (OS) and the disruption of the equilibrium between the production of reactive oxygen species and antioxidants are key molecular features of unhealthy aging. OS results in the formation of oxidative posttranslational modifications (PTMs), some of which involve cysteine (Cys) residues in aging proteomes, and specifically, the formation of trioxidized Cys (t-Cys), which leads to permanent protein damage. Recent findings in rodents have uncovered that irregular regulation of t-Cys residues in the aging proteome disrupts homeostatic phosphorylation signaling, resulting in alterations to proteins that are analogous to those caused by phosphorylated serine (p-Ser) residues. This work contextualizes these significant findings and discusses the implications and molecular role(s) of t-Cys in the aging proteome. Furthermore, we present novel data, validating the increase of specific t-Cys sites associated with aging in a blood-related circulating human proteome. The scope and findings included here support the hypothesis that t-Cys residues may serve as important mechanistic and biological markers, warranting further exploration in the context of unhealthy aging and age-related major diseases., Support for this work was provided by the National Institute of Health/Instituto de Salud Carlos III-ISCIII, Spain PI22/00443 and DTS24/00141 to X.G.-P.), grant co-funded by the European Union; the Ministry of Science and Innovation-MCIN, Spain and the National Research Council/Agencia Estatal de Investigación-AEI, Spain (PID2020-114885RB-C21 to A.S.) funded by MCIN/AEI/10.13039/501100011033. This research was also co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU; from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1); and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health ((EVBRAINTARGET-Y7340-ACPPCCOL007 to X.G.-P. and A.S) coordinated by the Institute for Bioengineering of Catalonia (IBEC)); the Diputació de Lleida, Spain (PIRS22/03 to X.G.-P. and PIRS23/02 to A.S.); the Catalan Research Council-AGAUR (2023 LLAV 00056 to X.G.-P.; and 2022 DI 100 to X.G.-P. X.G.-P. acknowledges a Miguel Servet program tenure track contract (CP21/00096) from the ISCIII, awarded on the 2021 call under the Health Strategy Action, co-funded by the European Union (FSE+). A.S. acknowledges a Ramón y Cajal program tenure track contract (RYC2021-030946-I) funded by MCIN/AEI/ 10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR. J.A.S.M.’s PhD scholarship (2023 FI-1 00054) is funded by AGAUR. M.M.’s PhD scholarship (PRE2021-097934) is funded by MCIN/AEI/ 10.13039/501100011033 and by “FSE+”. IRBLLEIDA, J.A.S.M., X.G.-P., and A.S. are co-funded by the CERCA Program/Generalitat de Catalunya. X.G.-P. is member of the ExoPsyCog Consortium, funded